Announcements 2025
Interim results for the six months ended 30 June 2025
Commercial Progress in USA : Advance Royalty Schedule Revised for Earlier Payment
Result of Annual General Meeting – 30 June 2025
Notice of Annual General Meeting – 30 June 2025
Holdings in Company : 28/05/2025
£150,000 Convertible Loan Note Issue
Final results for the year ended 31 December 2024 – 30/04/2025
First Hospital Laboratory Contract in Caribbean & Update on Launch of CIZ1B Biomarker Assay – 28/04/2025
Launch of New Website – 14/04/2025
Appointment of Non-Executive Director – 25/03/2025
First COLA and CLIA Accredited Laboratory in USA confirmed and Update of CIZ1B Biomarker Assay – 24/03/2025
Appointment of Professor Dawn Coverley Update on Launch of CIZ1B Biomarker Assay – 02/01/2025